CNL Turns Its Attention to Next-Generation of Medical Isotopes
During the talk, Lesinski discussed pre-clinical research CNL is conducting with leading Canadian research organizations to help enable medical treatments using actinium-225 to fight a wide spectrum of cancers and other diseases.
- During the talk, Lesinski discussed pre-clinical research CNL is conducting with leading Canadian research organizations to help enable medical treatments using actinium-225 to fight a wide spectrum of cancers and other diseases.
- For more information on CNL, including its work in targeted alpha therapy, please visit www.cnl.ca .
- With ongoing investments in new facilities and a focused mandate, CNL is well positioned for the future.
- For more information on the complete range of CNL services, please visit www.cnl.ca or contact [email protected] .